Publication | Closed Access

Use of Intravenous Stilbestrol Diphosphate in Patients with Prostatic Carcinoma Refractory to Conventional Hormonal Manipulation

UrologyConventional Hormonal ManipulationMedicineBenign Prostatic HyperplasiaPharmacotherapyProstatic DiseasePharmacologyIntravenous Stilbestrol DiphosphateProstatic Carcinoma RefractoryDrug Discovery